Clinical trial

Spironolactone Therapy in Chronic Stable Right HF Trial

NCT03344159

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-04-01

PhasePHASE4

Study timeline

Study start (actual)2018-04-01Date precision: day

Registry last updated2026-05-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Right-Sided Heart Failureunresolved

Pulmonary Arterial Hypertensionunresolved

Pulmonary Hypertension, Primary, 2unresolved

Pulmonary Hypertension, Primary, 3unresolved

Pulmonary Hypertension, Primary, 4unresolved

Cardiomyopathy Right Ventricularunresolved

Interventions

SpironolactoneDRUG · verified · RxNorm: spironolactone

PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82RADIATION

Cardiac MRI (Gadolinium enhanced)DIAGNOSTIC_TEST

Sponsors & collaborators

Ottawa Heart Institute Research Corporationlead sponsor

Mapped research locations

OttawaOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03344159 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.